P. L. Esposti
ORCID: 0000-0002-4243-7257
· 2 papers in corpus
No AccessJournal of Urology1 May 1986High-Dose Danazol Therapy in Prostatic Cancer Patients: Endocrine and Clinical Effects P.O. Hedlund, D. Freedman, P. Esposti, S. Gershagen, and K. Carlström P.O. HedlundP.O. Hedlund More articles by this…
The effect of an oral gonadotropin agent--Danazol--on 5 patients with prostatic carcinoma was investigated. A phase 2 pilot study, using a combination of repeated clinical findings, hormone analyses and cytological examinations, allowed som…